ProfileGDS4718 / 232419_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 66% 62% 68% 62% 59% 57% 68% 63% 64% 60% 60% 61% 56% 58% 64% 61% 62% 59% 65% 68% 64% 61% 62% 60% 57% 62% 57% 62% 62% 59% 57% 69% 63% 58% 54% 63% 64% 67% 61% 62% 61% 57% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1085460
GSM549102patient 115, normal, homogenized [OPG study]6.5736266
GSM549104patient 119, normal, homogenized [OPG study]6.2927662
GSM549108patient 138, normal, homogenized [OPG study]6.7035468
GSM549119patient 077, normal, homogenized [OPG study]6.2497462
GSM549133patient 032, cancer, homogenized [OPG study]6.0059859
GSM549139patient 042, cancer, homogenized [OPG study]5.891357
GSM549099patient 107, normal, homogenized [OPG study]6.6869968
GSM549109patient 139, normal, homogenized [OPG study]6.3672563
GSM549110patient 046, normal, homogenized [OPG study]6.396264
GSM549114patient 063, normal, homogenized [OPG study]6.0857960
GSM549122patient 082, normal, homogenized [OPG study]6.1218960
GSM549134patient 033, cancer, homogenized [OPG study]6.2010761
GSM549136patient 036, cancer, homogenized [OPG study]5.8448456
GSM549140patient 044, cancer, homogenized [OPG study]5.992158
GSM549111patient 047, normal, homogenized [OPG study]6.4013764
GSM549113patient 057, normal, homogenized [OPG study]6.1526461
GSM549132patient 031, cancer, homogenized [OPG study]6.2365162
GSM549137patient 038, cancer, homogenized [OPG study]6.072659
GSM549142patient 047, cancer, homogenized [OPG study]6.5334865
GSM549100patient 110, normal, homogenized [OPG study]6.6935268
GSM549107patient 135, normal, homogenized [OPG study]6.4039764
GSM549115patient 068, normal, homogenized [OPG study]6.147161
GSM549116patient 072, normal, homogenized [OPG study]6.2363462
GSM549120patient 078, normal, homogenized [OPG study]6.1412860
GSM549131patient 030, cancer, homogenized [OPG study]5.8726357
GSM549118patient 074, normal, homogenized [OPG study]6.245562
GSM549129patient 027, cancer, homogenized [OPG study]5.9405557
GSM549123patient 088, normal, homogenized [OPG study]6.2630462
GSM549124patient 006, cancer, homogenized [OPG study]6.2835762
GSM549126patient 015, cancer, homogenized [OPG study]6.0549759
GSM549128patient 025, cancer, homogenized [OPG study]5.9638457
GSM549103patient 117, normal, homogenized [OPG study]6.7493669
GSM549117patient 073, normal, homogenized [OPG study]6.3010463
GSM549138patient 041, cancer, homogenized [OPG study]5.9731858
GSM549141patient 045, cancer, homogenized [OPG study]5.72854
GSM549130patient 028, cancer, homogenized [OPG study]6.3167563
GSM549101patient 111, normal, homogenized [OPG study]6.4464264
GSM549105patient 128, normal, homogenized [OPG study]6.6376667
GSM549106patient 134, normal, homogenized [OPG study]6.1957561
GSM549112patient 048, normal, homogenized [OPG study]6.2415862
GSM549125patient 011, cancer, homogenized [OPG study]6.1730661
GSM549127patient 024, cancer, homogenized [OPG study]5.9996757
GSM549135patient 035, cancer, homogenized [OPG study]5.7750255